Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Long-term CR Multiple Myeloma Patients Show Cured or MGUS-like Minimal Residual Disease Pattern by Next Generation Flow.
Rev Recent Clin Trials. 2022;17(2):92-96. doi: 10.2174/1574887117666220516145628.
Rev Recent Clin Trials. 2022.
PMID: 35578845
"Friends and foes" of multiple myeloma measurable/minimal residual disease evaluation by next generation flow.
Pacelli P, Raspadori D, Bestoso E, Gozzetti A, Bocchia M.
Pacelli P, et al. Among authors: bestoso e.
Front Oncol. 2022 Nov 28;12:1057713. doi: 10.3389/fonc.2022.1057713. eCollection 2022.
Front Oncol. 2022.
PMID: 36518304
Free PMC article.
Review.
Item in Clipboard
Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26+ leukemia stem cells.
Pacelli P, Santoni A, Sicuranza A, Abruzzese E, Giai V, Crugnola M, Annunziata M, Galimberti S, Iurlo A, Luciano L, Sorà F, Fava C, Bestoso E, Marzano C, Cartocci A, Defina M, Sammartano V, Cencini E, Raspadori D, Bocchia M.
Pacelli P, et al. Among authors: bestoso e.
Front Pharmacol. 2023 May 26;14:1194712. doi: 10.3389/fphar.2023.1194712. eCollection 2023.
Front Pharmacol. 2023.
PMID: 37305536
Free PMC article.
Item in Clipboard
Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients.
Correale P, Botta C, Basile A, Pagliuchi M, Licchetta A, Martellucci I, Bestoso E, Apollinari S, Addeo R, Misso G, Romano O, Abbruzzese A, Lamberti M, Luzzi L, Gotti G, Rotundo MS, Caraglia M, Tagliaferri P.
Correale P, et al. Among authors: bestoso e.
Cancer Biol Ther. 2011 Jul 15;12(2):112-8. doi: 10.4161/cbt.12.2.15722. Epub 2011 Jul 15.
Cancer Biol Ther. 2011.
PMID: 21525780
Clinical Trial.
Item in Clipboard
Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro.
Correale P, Botta C, Cusi MG, Del Vecchio MT, De Santi MM, Gori Savellini G, Bestoso E, Apollinari S, Mannucci S, Marra M, Abbruzzese A, Aquino A, Turriziani M, Bonmassar L, Caraglia M, Tagliaferri P.
Correale P, et al. Among authors: bestoso e.
Int J Cancer. 2012 Apr 1;130(7):1577-89. doi: 10.1002/ijc.26181. Epub 2011 Aug 16.
Int J Cancer. 2012.
PMID: 21618510
Free article.
Item in Clipboard
Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients.
Botta C, Bestoso E, Apollinari S, Cusi MG, Pastina P, Abbruzzese A, Sperlongano P, Misso G, Caraglia M, Tassone P, Tagliaferri P, Correale P.
Botta C, et al. Among authors: bestoso e.
J Immunother. 2012 Jun;35(5):440-7. doi: 10.1097/CJI.0b013e31825943aa.
J Immunother. 2012.
PMID: 22576349
Clinical Trial.
Item in Clipboard
Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: the GOLFIG-2 multicentric open-label randomized phase III trial.
Correale P, Botta C, Rotundo MS, Guglielmo A, Conca R, Licchetta A, Pastina P, Bestoso E, Ciliberto D, Cusi MG, Fioravanti A, Guidelli GM, Bianco MT, Misso G, Martino E, Caraglia M, Tassone P, Mini E, Mantovani G, Ridolfi R, Pirtoli L, Tagliaferri P.
Correale P, et al. Among authors: bestoso e.
J Immunother. 2014 Jan;37(1):26-35. doi: 10.1097/CJI.0000000000000004.
J Immunother. 2014.
PMID: 24316553
Clinical Trial.
Item in Clipboard
Cite
Cite